Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1091 | 1064 | 1151 | 1273 | 1447 | 2091 |
Fund Return | 9.09% | 6.41% | 15.11% | 8.37% | 7.67% | 7.65% |
Place in category | 166 | 279 | 173 | 302 | 591 | 104 |
% in Category | 6 | 11 | 7 | 17 | 37 | 7 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Goldman Sachs Global CORE Equity Pe | 4.02B | 11.26 | 8.42 | 10.95 | ||
GS Global CORE Equity Portfolio E C | 4.02B | 10.18 | 8.17 | 10.78 | ||
GS Global CORE Equity Portfolio I E | 4.02B | 10.63 | 9.57 | 12.25 | ||
GS India Equity Portfolio E Acc | 3.64B | 10.67 | 15.96 | 14.54 | ||
GS EM Equity Portfolio E Acc | 3.06B | 7.26 | -7.42 | 5.58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 179.09M | 5.53 | 4.70 | 5.19 | ||
European Growth Fund E Acc EUR | 21.55M | 5.25 | 3.90 | 4.40 | ||
European Growth Fund Y Acc EUR | 137.47M | 5.76 | 5.56 | 6.05 | ||
European Growth Fund A DIST Eue | 6.42B | 5.54 | 4.70 | 5.19 | ||
European Growth Fund Y DIST EUR | 64M | 5.81 | 5.59 | 6.05 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.48 | 937.4 | +1.56% | |
ASML Holding | NL0010273215 | 5.24 | 876.40 | +2.61% | |
Nestle | CH0038863350 | 3.27 | 93.30 | -1.85% | |
Novartis | CH0012005267 | 2.43 | 92.77 | -0.42% | |
Schneider Electric | FR0000121972 | 1.92 | 235.75 | +1.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review